Tony Lowman, Provost/Sr. VP for Academic Affairs at Rowan University shares his entrepreneurial journey with his startup ReGelTec. The Baltimore-based startup is developing a gel that can be injected into the nucleus of a lumbar (or lower back) disc for patients who had surgery related to degenerative disc disease.The spinal implants are designed to return spacing and height that is lost during surgery to the disc, when some of the nucleus is removed. ReGelTec maintains a lab at Rowan University in Glassboro, New Jersey. Visit https://www.regeltec.com/ to learn more.